Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team
Share
You are reading a summary. The full content is hosted on eu-startups.com.
Vienna-based Epitome Therapeutics, a BioTech company advancing precision epigenome editing for programmable gene expression, today announced a total funding of €4 million to advance development programmes and grow the company’s team. The pre-seed round, comprising an oversubscribed €2 million pre-seed round and €2 million in non-dilutive grant funding, was co-led by XISTA Science Ventures and […] The post Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team appeared first on EU-Startups.
External link to eu-startups.com
Related Articles
startup
Sources: Uber halts plans to launch food delivery in five of the seven European countries it had targeted for expansion as it pursues a Delivery Hero takeover (Kieran Smith/Financial Times)
startup
India issues a notice to Telegram, asking it to curb the spread of pirated films and other copyrighted content, and seeks an action-taken report within 15 days (Sejal Sharma/Hindustan Times)
startup
